Navigation Links
Beckman Coulter Prices $500 Million Senior Notes Offering
Date:5/18/2009

ORANGE COUNTY, Calif., May 18 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer and marketer of products that simplify, automate and innovate complex biomedical testing, announced today the pricing of its senior notes offering of:

  • $250 million of Senior Notes that mature in 2015 and bear interest at a rate of 6%, and

  • $250 million of Senior Notes that mature in 2019 and bear interest at a rate of 7%.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

This offering is being made pursuant to an effective shelf registration statement on file with the Securities and Exchange Commission and is expected to close May 21, 2009, subject to customary conditions. Citigroup Global Markets Inc., J.P. Morgan Securities Inc. and Morgan Stanley & Co. Incorporated are acting as active joint book-running managers for the offering.

Beckman Coulter expects to use the net proceeds from this offering of approximately $495 million to finance a portion of the acquisition price for the diagnostic systems portion of Olympus Corporation's Life Science business and for general corporate purposes. Pending the application of the net proceeds, Beckman Coulter plans to invest the net proceeds in U.S. government obligations, bank deposits or in other secure, short-term investments.

Certain statements in this news release may be deemed to include forward-looking statements, such as statements that relate to this offering and whether Beckman Coulter will consummate this offering. Forward-looking statements are typically identified by words or phras
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Beckman Coulter to Present at the Bear Stearns Healthcare Conference
2. Beckman Coulter to Present at the UBS Global Life Sciences Conference
3. Beckman Coulter Announces Third Quarter 2007 Earnings to Be Released on Tuesday, October 30, 2007 Before Market Opens
4. Beckman Coulter Declares Quarterly Dividend
5. Beckman Coulter Announces Third Quarter 2007 Results
6. Beckman Coulter to Present at the 19th Annual Piper Jaffray Healthcare Conference
7. Beckman Coulter to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
8. Beckman Coulter to Acquire Exclusive Rights to Break-Through Technologies
9. Beckman Coulter Elects AMN Healthcare Executive to Board of Directors
10. Beckman Coulter to Present at the JPMorgan Healthcare Conference
11. AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...v. 30 Acuo Technologies, developer...tware, data migration tools and services, today an...ics for a new Vendor Neutral Archive (VNA), provid...ina network of hospitals, clinics and affiliates. ...Technologies DICOM Services Grid(TM) Software. Th...
(Date:11/30/2009)...er 30 Biopharmaceutical company Ki...s have been enrolled in its,multinational registra...signed to show reduction in transplant related mor...c stem cell transplantation with a mismatched,(hap...ble for an allogeneic,stem cell transplantation bu...
(Date:11/30/2009)... BioMarin Pharmaceutical...od and Drug Administration (FDA) has granted orpha...P), amifampridine phosphate, for the rare autoimmu...). 3,4-DAP has previously received orphan drug de...Committee for Medicinal Products for Human Use of ...
(Date:11/30/2009).... 30 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: ...d medical-device research and,development outsourc...d States,announced that it had been selected to t... the fifth consecutive year. The list recognizes t...ogy, media, and telecommunications,industries base...
Breaking Biology Technology:Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2
...e BIO 2005 meeting in Philadelphia last month, the...U.S. roots has really taken flight. The company th...s Ernst & Young in its annual report on biotechnol...wed at the annual BIO meeting. This years report, ...: Global Biotechnology Report 2005, is a treasure ...
... citizen may think Gov. Jim Doyle and the Republic...ever they step into the boxing ring of politics. A...at have taken place in the Capitol over the past t... largely correct. , ,Not entirely correct, however...ined in the 2005-2007 budget bill. , ,The bill sig...
...Technologies , a provider of molecular diagnostics...in line with market expectations. , ,Third Wave re...s of $5.5 million, or 13 cents per diluted share, ...otal revenue of $12.6 million and a net loss of $1...me period of 2004. , ,Despite the losses, the comp...
Other Biology Technology:Globalization of biotech industry is a decidedly worldwide phenomenon 2Globalization of biotech industry is a decidedly worldwide phenomenon 3State tax compromises prove that partisanship can be set aside for a while 2State tax compromises prove that partisanship can be set aside for a while 3Transition continues to impact Third Wave financials 2
(Date:11/30/2009)...w Orleans, LA Researchers from LSU Health Science...ce Kennedy Shriver National Institute of Child Hea...of Public Health, Brigham and Women,s Hospital, an... time that drinking more than 5 servings of sugar-...to significantly elevate the risk of developing di...
(Date:11/30/2009)...e Editors of The Journal of Experimental Biology ...m Centre National de la Recherche Scientifique (CN...he winner of this year,s JEB Outstanding Paper P...utstanding achievement and is intended to encourag... Editor-in-Chief, and adds that ,we truly appreci...
(Date:11/30/2009)...o so-called invasion proteins are crucial for infe...ce of human cells, which stimulates the host cell ...molecules exert a different function, for example ...he group,s results have now been published in the ...y ". , Spoiled meat is one of the sources for L...
Breaking Biology News(10 mins):Sugary cola drinks linked for first time to higher risk of gestational diabetes 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4It takes 2 to infect 2AccuVein Inks National Three Year Group Purchasing Deal With Amerinet 12519 1AccuVein Inks National Three Year Group Purchasing Deal With Amerinet 12519 2CyberKnife Center of Miami Executive Director James G Schwade M D Garners Ultimate Miami CEO Award 48158 1Members of National CHD Organization Unite for Little Hearts Celebration and Assemble for Picture of Hope 48154 1Members of National CHD Organization Unite for Little Hearts Celebration and Assemble for Picture of Hope 48154 2
...N, N.J. Katherine Freed, undergraduate at Stevens...nternational ISPE Undergraduate Poster Contest in ...mpetitor from New Jersey to win this ISPE award. H...d on a project she created with her Senior Design ...gional ISPE Poster Contest was hosted by the Steve...
... release is available in Spanish . , Idiopathic ... with a very severe prognosis; when detected, it i... from it cannot develop with normality pulmonary g...fe. Because of lack of an effective treatment, the...iopathic pulmonary fibrosis affects 13 out of 100,...
...svirus May Play Role in Central Nervous System Dis...esting a herpesvirus may be responsible for some c...from the New York State Department of Public Healt...n the December 2007 issue of the Journal of Clinic... one of the most prevalent in humans. There are t...
Other Biology News:Katherine Freed wins first place at the International ISPE Undergraduate Poster Contest 2Translational research patented first experimental treatment against idiopathic pulmonary fibrosis 2Tips from the Journals of the American Society for Microbiology 2Tips from the Journals of the American Society for Microbiology 3
...are intended for laboratory research use only. Th...d formalin and embedded in paraffin. Tissue ident... pathologists. Tissue cores were removed from the...ent paraffin block, in an array pattern, using Che...
...Microarrays Using the New FAST(tm) Frame Multi-Sli...esigned to hold four, 16-pad FAST Slides and the c...icroplate footprint for high throughput processing... standards recommended by the Society of Biomolecu...
a-Hyb Hybridization Station from Miltenyi Biotec
...ve been designed to save time and provide contamin...in eliminating the recycling and resterilizing nec...ividually packaged, RNase/DNase free, non-pyrogeni...w product number, created to easily match Cornings...
Biology Products: